Liquidia (LQDA) stock price, chart and financials
Price chart
Financials
- Revenue (quarter)
- $171.7M
- Revenue growth (year over year)
- +1842.73%
- Gross margin
- 92.54%
- Net income (quarter)
- $74.7M
- Net margin
- 30.74%
- Return on equity
- 131.82%
- Book value per share
- $2.19
- Price to book
- 15.96
- Debt to assets
- 62.62%
Company profile
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Frequently asked questions
Is Liquidia (LQDA) profitable?
Yes. Liquidia earned $138.6M in net income over the trailing twelve months, a net margin of 30.74%.
How much revenue does Liquidia (LQDA) make?
Liquidia generated $450.9M in revenue over the trailing twelve months, up 1842.73% year over year.
What is LQDA's P/E ratio?
Liquidia trades at 22.5 times trailing twelve-month earnings, on an EPS of $1.58.
How do I buy stock in Liquidia (LQDA)?
LQDA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
